Materialise to Launch TRUMATCH® Personalized Solutions Shoulder System
March 06 2018 - 8:00AM
Business Wire
Expanded collaboration with DePuy Synthes provides surgeons
access to online planning platform and 3D printed guides for
shoulder surgery.
Materialise NV (Nasdaq:MTLS) launched a shoulder planner for
surgeons with the possibility to plan shoulder arthroplasty cases
and order patient-specific shoulder guides, in collaboration with
DePuy Synthes. The TRUMATCH® Personalized Solutions Shoulder
System, revealed at the AAOS Annual Meeting in New Orleans, marks a
further extension of Materialise’s longstanding collaboration with
DePuy Synthes, who will distribute the solution in the United
States, Canada, Australia, New Zealand and Europe.
The TRUMATCH® Personalized Solutions Shoulder System will help
orthopaedic surgeons prepare for shoulder arthroplasty surgery,
specifically addressing Reverse Shoulder Arthroplasty (RSA) and
Anatomic Total Shoulder Arthroplasty (TSA) operations. It offers
surgeons an all-in-one, web-based platform that allows them to
better plan and prepare for these operations as well as order
patient specific 3D printed surgical guides.
RSA and TSA operations present unique challenges, with limited
visibility as the result of the small incision, the Glenoid cavity
being deep in the surgical window and the lack of reliable
landmarks. However, precise alignment is required, not just because
of limited bone stock, but because of its impact on overall screw
length and fixation (with RSA) and the occurrence of peg
perforation (with TSA).
Compared to using 2D images to diagnose and perform a shoulder
arthroplasty, pre-surgical planning lets surgeons know what to
expect upfront, working in three dimensions. With 3D virtual
pre-surgical planning, implant positioning is done within a stable
reference frame, linked to the entire scapula, using reliable
landmarks that are not subject to case specific wear patterns. This
allows the surgeon to be more precise in the alignment of the
implant and screw positioning, improving overall fixation. The
measurement, viewing and implant positioning features of the
TRUMATCH® Personalized Solutions Shoulder System helps surgeons
make better informed, clinical decisions before, rather than during
surgery, taking control of an important step for a more desired
outcome. This increased pre-operative preparedness gives the
surgeon and the team more confidence and control during
surgery.
As a result of the pre-operative planning, surgeons may decide
to execute the surgery with personalized guides if it’s believed
that conventional instruments or standard guides are less
appropriate because of glenoid deformities. The TRUMATCH®
Personalized Solutions Shoulder System also allows surgeons to
order patient specific 3D printed shoulder guides within the same
platform.
“3D planning is gaining popularity with orthopaedic surgeons
performing shoulder operations,” said Wilfried Vancraen, Founder
and CEO of Materialise. “Together with our strategic partners like
DePuy Synthes, we are continually working to improve surgical
planning processes for a range of operations. We are proud that
this expanded collaboration will empower even more orthopaedic
surgeons to discover the benefits of online planning and
3D-printed, patient-specific surgical guides.”
Materialise is exhibiting during the annual meeting for the
American Academy of Orthopaedic Surgeons, March 6-10, 2018 in New
Orleans. The company hosts live software demonstrations and expert
talks on booth #3729 as well as a lunchtime presentation on March 7
in the Technology Theatre. Learn more at
http://www.materialise.com/en/medical/orthopaedic-surgeons-meeting-2018.
About MaterialiseMaterialise incorporates 27 years of 3D
printing experience into a range of software solutions and 3D
printing services, which together form the backbone of the 3D
printing industry. Materialise’s open and flexible solutions enable
players in a wide variety of industries, including healthcare,
automotive, aerospace, art and design, and consumer goods, to build
innovative 3D printing applications that aim to make the world a
better and healthier place. Headquartered in Belgium, with branches
worldwide, Materialise combines the largest group of software
developers in the industry with one of the largest 3D printing
facilities in the world. For additional information, please visit:
www.materialise.com.
About Materialise’s Medical DivisionMaterialise Medical,
which has pioneered many of the leading medical applications of 3D
printing, enables researchers, engineers and clinicians to
revolutionize innovative patient-specific care. Materialise
Medical’s open and flexible platform of software and services,
Materialise Mimics, forms the foundation of certified Medical 3D
Printing, in clinical as well as research environments, offering
virtual planning software tools, 3D-printed anatomical models, and
patient-specific surgical guides and implants. For additional
information, please visit: medical.materialise.com.
Cautionary Statement on Forward-Looking StatementsSome of
the statements in this press release are "forward-looking" and are
made pursuant to the safe harbor provision of the Private
Securities Litigation Reform Act of 1995. These forward-looking
statements include statements relating to, among other things, our
planned commercialization efforts and regulatory approvals of our
technologies as well as the success thereof and our research and
development projects. These forward-looking statements are based
upon the expectations of management under current assumptions at
the time of this press release. We caution you that forward-looking
statements are not guarantees of future performance and involve
known and unknown risks, uncertainties and other factors that are
in some cases beyond our control that may cause our actual results
to differ materially from our expectations. We are providing this
information as of the date of this press release and do not
undertake any obligation to update any forward-looking statements
contained in this presentation as a result of new information,
future events or otherwise, unless we have obligations under the
federal securities laws to update and disclose material
developments related to previously disclosed information.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20180306005849/en/
Press Contacts:MaterialiseVirginia GobleVice
President Marketing-North AmericaMobile: (248) 921-5500Email:
virginia.goble@materialise.com or press@materialise.comTwitter:
@MaterialiseNVVisit: www.materialise.comorFrancoMegan
PetersonMobile: 248.330.9807Email: peterson@franco.com
Materialise NV (NASDAQ:MTLS)
Historical Stock Chart
From Apr 2024 to May 2024
Materialise NV (NASDAQ:MTLS)
Historical Stock Chart
From May 2023 to May 2024